|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Division of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona (J.W., J.H., J.D., Q.L., K.-C.Y.); Department of Cardiovascular Pharmacology, Institute of Pharmacology and Toxicology, Beijing, People's Republic of China (J.W., Y.-P.C., H.W.); Department of Medical Technology, Hirosaki University School of Health Science, Hirosaki, Japan (T.T.); Department of Physiology I, Hirosaki University School of Medicine, Hirosaki, Japan (S.S., M.W.); Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona (P.A.S.); and Department of Pharmacology, Nanjing University of Medical Science, Nanjing, People's Republic of China (J.W., J.H., G.H.)
Received for publication
April 14, 2006
Accepted
July 10, 2006.
| Abstract |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Immunocytochemical Staining to Identify Dissociated DA Neurons and SUR1 and SUR2B Protein Expression. For identification of DA neurons, single dissociated neurons were fixed for 5 min with methanol at -20°C. After fixation, the cells were permeabilized with 1 mg/ml saponin (Sigma Chemical Co., St. Louis, MO) in water for 5 min at room temperature. The samples were incubated overnight at 4°C with tyrosine hydroxylase (TH) primary antibody (AB152; Chemicon International Inc., Temecula, CA) in phosphate-buffered saline (PBS), which contained 5% bovine serum albumin. The cells were then rinsed with PBS and incubated with cy3-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA) for 1 h at room temperature. After three additional rinses with PBS, the samples were examined under a Zeiss fluorescence microscope (Zeiss, Oberkochen, Germany), and images were processed using Photoshop (Adobe Systems Inc., San Jose, CA; Fig. 1A). To identify protein expression of SUR1 and SUR2B subunits of KATP channels, single dissociated SNc neurons were fixed and permeabilized in the same manner as described previously. The samples were then incubated overnight in SUR1 or SUR2B primary antibody (sc-25683 and sc-5793, respectively; Santa Cruz Biotechnology Inc., Santa Cruz, CA). The cells were subsequently rinsed with PBS and incubated with fluorescein isothiocyanate-conjugated secondary antibodies (sc-2012 and sc-2024; Santa Cruz Biotechnology Inc.) for at least 2 h before final rinses and fluorescence microscopy. Both the primary and secondary antibodies were diluted with PBS, which contained 5% bovine serum albumin.
|
when filled with the internal solution. A tight seal (>2 G
) was formed between the electrode tip and the cell surface, which was followed by a transition from on-cell to whole-cell recording mode due to the partitioning of amphotericin B into the membrane underlying the patch. After whole-cell formation, an access resistance lower than 60 M
was acceptable during perforated-patch recordings in current-clamp mode, and an access resistance lower than 30 M
was acceptable during voltage-clamp recordings. The series resistance was not compensated in the experiments using dissociated neurons. Under current-clamp configuration, membrane potentials were measured using a patch-clamp amplifier (200B; Axon Instruments, Foster City, CA). Data were filtered at 2 kHz, acquired at 11 kHz, and digitized on-line (Digidata 1322 series A/D board; Axon Instruments). All experiments were performed at room temperature (22 ± 1°C). Heterologous Expression of Kir6.2/SUR1 KATP Channels in Cultured HEK-293 Cells and Whole-Cell Patch-Clamp Recordings. HEK-293 cells were cultured in plastic dishes (9.4 cm in diameter) at 37°C in a humidified atmosphere of 95% air and 5% CO2 in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum. Cells were transiently transfected using Lipofectamine reagent (Lipofectamine 2000; Invitrogen) mixed with pcDNA3.1 vector, which contained cDNA encoding SUR1 or Kir6.2 in serum-free medium. As a control, cells were transfected with pcDNA3.1 vector alone. The cells were transiently cotransfected with vectors encoding SUR1 and Kir6.2 subunits at a molar plasmid ratio of 1:2. A marker gene encoding green fluorescent protein (pEGFP-N1; Clontech, Mountain View, CA) was cotransfected with the cDNA at a ratio of 1:10 to allow the transfected cells to be identified by epifluorescence. Transfection was performed according to the manufacturer's instructions. The cells were allowed to express the products of the transfected DNA for 48 h and were then used for electrophysiological experiments. Conventional whole-cell patch-clamp recordings were used to test the functional Kir6.2/SUR1 KATP channels expressed in cultured HEK-293 cells. Whole-cell currents were recorded in voltage-clamp mode. Series resistance during whole-cell recordings was compensated to at least 75%. Cells were bathed in a symmetrical potassium solution, and currents were elicited from a holding potential of 0 mV in a 100-ms voltage step to +50 mV. Electrophysiological data were analyzed using pClamp 9.2 (Axon Instruments) and Origin software (5.0; Microcal, Northampton, MA).
Measurement of Mitochondrial Membrane Potential Using Fluorescence Imaging. The mitochondrial membrane potential was measured using rhodamine-123 (Rh-123) fluorescent dye imaging. Rh-123 is a cell-permeant, cationic, fluorescent dye that is readily uptaken by active mitochondria. The uptake of Rh-123 by mitochondria is directly correlated to the membrane potential of mitochondria, suggesting that uptake is probably driven by mitochondrial membrane potential. The linear relationship of the change in Rh-123 fluorescence and mitochondrial membrane potential, the dependence of its uptake by mitochondrial membrane potential, and its low cytotoxicity make this dye an excellent indicator of mitochondrial membrane potential (Chen, 1988
). Dissociated neurons were placed in a glass-bottom culture dish and then loaded with 10 µg/ml Rh-123 (Sigma) at room temperature for 10 min. After loading, the neurons were continuously perfused with buffer that contained 140 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 1.0 mM CaCl2, 10 mM glucose, and 10 mM HEPES. Rh-123 fluorescence images were captured using an inverted microscope with 40x Plan-Neofluar objectives (Axiovert 135; Zeiss) and a silicone intensifier target camera and were recorded on a fluorescence-imaging system (Argus 50/CA; Hamamatsu Photonics, Hamamatsu, Japan). The fluorescence was excited at 490 nm and filtered at 530 nm.
Solutions and Drugs. The composition of the ACSF was 124 mM NaCl, 5 mM KCl, 24 mM NaHCO3, 1.3 mM MgSO4, 1.2 mM KH2PO4, 2.4 mM CaCl2, and 10 mM glucose, pH 7.4, bubbled with 95% O2-5% CO2. The composition of the standard external solution for DA neuronal recordings was 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glucose, and 10 mM HEPES, and the pH was adjusted to 7.4 using Tris base. The external solution for HEK-293 cell recordings was composed of 140 mM KCl, 1.2 mM MgCl2, 2.6 mM CaCl2, and 5.0 mM HEPES, pH 7.4. The amphotericin B perforated-patch pipette solution contained 130 mM potassium gluconate, 10 mM KCl, 5 mM MgCl2, and 10 mM HEPES, pH 7.2 (using Tris-OH). The liquid junction potential, calculated using Clampex 9.2 (Axon Instruments), was 14 mV and corrected post hoc. Amphotericin B was dissolved in dimethyl sulfoxide (40 mg/ml), and the stock solution was diluted with internal (patch-pipette) solution to achieve a final concentration of 200 to 300 µg/ml just before use. The pipette solution for conventional whole-cell recordings contained 107 mM KCl, 1.2 mM MgCl2, 1.0 mM CaCl2, 10 mM EGTA, 5.0 mM HEPES, and 3.0 mM MgATP, pH 7.3. Pronase was purchased from Calbiochem-Novabiochem Co. (La Jolla, CA); rotenone, tolbutamide, caffeine, thermolysin, amphotericin B, and Lucifer yellow were purchased from Sigma. All other chemicals were purchased from Tocris Cookson, Inc. (Ballwin, MO), with the exception of iptakalim, which was a gift from Dr. H. Wang (Institute of Pharmacology and Toxicology, Beijing, People's Republic of China).
| Results |
|---|
|
|
|---|
To examine functional KATP channels in single DA neurons, perforated patch-clamp recordings were employed. In current-clamp mode, application of the SUR1-selective KCO diazoxide hyperpolarized the membrane and reduced spontaneous action potential firing (Fig. 1D, n = 6), whereas the SUR2B-containing KCO cromakalim (Avshalumov et al., 2005
) exhibited little effect on action potential firing (Fig. 1E), and similar insignificant results were obtained from five other neurons in four experiments. Before and during exposure to KCOs, the frequency of spontaneous action potential firing was 2.0 ± 0.1 and 0.9 ± 0.1 Hz for diazoxide (p < 0.01, n = 6) and 1.5 ± 0.1 and 1.6 ± 0.1 Hz for cromakalim (p > 0.05, n = 6), respectively. Figure 1F shows that rotenone (100 nM) induced gradual membrane hyperpolarization, which was accompanied by a reversible abolishment of spontaneous action potential firing. Similar results were obtained from 10 neurons. To determine whether rotenone-induced hyperpolarization was mediated through the opening of pm-KATP channels, the classic KATP channel blocker tolbutamide was applied in each case, and the results demonstrate that 100 µM tolbutamide completely reversed rotenone-induced hyperpolarization (Fig. 1F). Because it is known that neuronal KATP channels are mostly composed of Kir6.2 and SUR1 and/or SUR2B subunits (Liss et al., 1999a
, 2005
), these results suggest that functional pm-KATP channels (diazoxide- and tolbutamide-sensitive but cromakalim-insensitive) in rat SNc DA neurons are probably composed of Kir6.2 and SUR1 subunits.
Protein Expression of SUR1 and SUR2B Subunits of KATP Channels in SNc DA Neurons. To explore the expression of SUR1 and/or SUR2B subunits of KATP channels in dissociated rat SNc DA neurons, double immunocytochemical staining using selective SUR1 and SUR2B antibodies was applied. Figure 2A represents an example of double staining in dissociated neurons using SUR1 and SUR2B antibodies ("SUR1" and "SUR2B," in the presence of both subunit primary antibodies) and shows a SUR1-positive (red) but SUR2B-negative reaction. In 24 dissociated neurons from four experiments, 20 neurons showed a SUR1-positive reaction (83%), and four neurons showed a SUR1-negative reaction (17%), whereas no SUR2B-positive reaction was observed. The bottom row of Fig. 2A shows a negative reaction using only secondary antibodies to SUR1 and SUR2B (SUR1- and SUR2B-, in the absence of both subunit primary antibodies). From four additional experiments, double staining was applied using either TH and SUR1 (Fig. 2B, top row) or TH and SUR2B (Fig. 2B, bottom row) antibodies. The results demonstrate that 83 of 90 TH-positive neurons expressed SUR1 (Fig. 2B, green), whereas only seven of 61 TH-positive neurons expressed SUR2B. These results suggest that DA neurons acutely dissociated from rat SNc mainly express the SUR1 subunit together with the Kir6.2 subunit to form functional KATP channels.
|
Iptakalim Failed to Open pm-KATP Channels. In identified DA neurons, iptakalim, at a concentration of 3 µM, exhibited little effect on spontaneous action potential firing (Fig. 3A). However, 100 µM iptakalim increased spontaneous action potential firing in three of six DA neurons (data not shown), whereas 300 µM iptakalim increased spontaneous action potential firing in all of the tested DA neurons (Fig. 3B). Before and during exposure to iptakalim, the frequency of spontaneous action potential firing was 2.1 ± 0.2 and 1.9 ± 0.2 Hz for 3 µM (p > 0.05, n = 4), 2.1 ± 0.2 and 2.3 ± 0.1 Hz for 100 µM (p > 0.05, n = 6), and 1.6 ± 0.2 and 2.9 ± 0.2 Hz for 300 µM (p < 0.01, n = 6), respectively. Figure 3C shows that tolbutamide (300 µM), a selective SUR1-containing KATP channel blocker, also increased DA neuron firing frequency from 2.2 ± 0.1 to 2.7 ± 0.3 Hz (p < 0.05, n = 4). Figure 3D shows that 300 µM iptakalim increased DA firing frequency. These results suggest that iptakalim failed to directly open pm-KATP channels in single DA neurons acutely dissociated from rat SNc. Instead, iptakalim, at relatively high concentrations, closed pm-KATP channels.
|
Iptakalim Reversed pm-KATP Channel-Mediated Hyperpolarization. In general, KATP channels expressed in central neurons are maintained at a closed status under physiological conditions (Busija et al., 2004
). However, in midbrain slices, the KATP channel blocker glibenclamide increases DA neuronal firing frequency (Avshalumov et al., 2005
), suggesting a spontaneous background opening of KATP channels occurs using in vitro preparations. Therefore, the above results (i.e., Fig. 3, B and D) suggest that iptakalim-induced increase of neuronal firing may be mediated through an inhibition of such background KATP channel activity. To determine whether iptakalim closes pm-KATP channels, we examined the effects of iptakalim on rotenone-induced KATP channel opening using current-clamp recordings. As shown in Fig. 4A, 100 nM rotenone-induced membrane hyperpolarization was reversed, action potential firing was completely restored by tolbutamide (300 µM), and iptakalim (100 µM) showed similar restorative effects on action potential firing, whereas other KCOs, such as pinacidil (100 µM), diazoxide (100 µM), and P1075 (100 µM), failed to reverse rotenone-induced hyperpolarization. After spontaneous action potential firing recovery after several minutes of washout of rotenone, the KCO diazoxide hyperpolarized DA neurons, which was reversed by iptakalim as well. Similar results were obtained from five other neurons. These results suggest that iptakalim, in particular at high concentrations, probably functions as a pm-KATP channel blocker. Figure 4B shows that iptakalim reversed rotenone-induced hyperpolarization in a concentration-dependent manner.
|
|
Iptakalim Suppressed Kir6.2/SUR1 KATP Channels Heterologously Expressed in Cultured HEK-293 Cells. Data presented thus far suggest that the majority of functional KATP channels in rat SNc DA neurons seem to be composed of Kir6.2 and SUR1 subunits and that iptakalim failed to open, but rather likely closed, these KATP channels. To further confirm these possibilities, we examined the effects of iptakalim on Kir6.2/SUR1 KATP channels heterologously expressed in cultured HEK-293 cells. A depolarizing pulse from 0 to +50 mV (100-ms duration) was applied to a HEK-293 cell transfected with Kir6.2 and SUR1 subunits at a holding potential of 0 mV under a symmetrical internal and external K+ (140 mM) condition, and only a tiny leak current was observed (Fig. 6A). Using the same experimental protocol, bath-applied iptakalim (100 µM) showed no significant effects on membrane current (Fig. 6B), but diazoxide (200 µM), on the other hand, induced a large outward current (Fig. 6C), which was blocked by glibenclamide (10 µM), a KATP channel blocker (data not shown). These data suggest that diazoxide opened Kir6.2/SUR1 KATP channels. Coapplication of 200 µM diazoxide and 300 µM iptakalim (Fig. 6D) or 500 µM iptakalim (Fig. 6E) reduced diazoxide-induced current. In addition, our preliminary results showed that both diazoxide (200 µM, n = 6) and iptakalim (100 µM, n = 6) did not show detectable current induction in wild-type HEK-293 cells (data not shown). Figure 6F summarizes the results from four cells and shows that iptakalim alone did not enhance membrane current; instead, it suppressed diazoxide-induced membrane current. These results support the notion that iptakalim did not open, but rather closed, Kir6.2/SUR1 KATP channels in SNc DA neurons.
|
|
Iptakalim Failed to Prevent Rotenone-Induced Mitochondrial Depolarization. Because iptakalim reversed rotenone-induced pm-KATP channel-mediated hyperpolarization, we examined whether iptakalim also prevents rotenone-induced mitochondrial depolarization. As shown in Fig. 8, 100 µM iptakalim failed to prevent rotenone-induced depolarization (n = 4), suggesting that iptakalim did not block mito-KATP channels in rat SNc DA neurons.
|
| Discussion |
|---|
|
|
|---|
Iptakalim, as a cardiovascular KCO, exhibited clear antihypertensive effects in hypertensive animal models that used in vivo and in vitro preparations (Wang, 2003
; Wang et al., 2005a
). The possible mechanisms underlying its antihypertensive action include the opening of cardiovascular KATP channels (Wang, 2003
). In primary cultured hippocampal neurons, iptakalim selectively potentiated voltage-activated K+, but not Na+ or Ca2+, currents (Wang et al., 2004
). Furthermore, [3H]iptakalim was reported to bind to SUR receptors of KATP channels in rat cerebral cortex, hippocampus, and striatum membrane preparations (Wang et al., 2004
). Based on these results, it was postulated that iptakalim served as a KCO that may protect cells against hypoxia/ischemia- and neurotoxin-induced neuronal degeneration (Wang et al., 2005a
; Yang et al., 2005a
,b
,c
). However, thus far, there is still no direct experimental evidence supporting the hypothesis that iptakalim is able to directly open pm-KATP channels and/or mito-KATP channels in SNc DA neurons, the neurons that are key targets in both PD patients and PD animal models.
In the present study, we clearly demonstrate that the mitochondrial complex I inhibitor rotenone and the relatively selective SUR1-containing KCO diazoxide opened pm-KATP channels in freshly dissociated rat SNc DA neurons using perforated patch-clamp recordings, which is consistent with previous reports (Liss et al., 1999a
,b
). In addition, using fluorescence-imaging methods, we also show that both diazoxide and rotenone depolarized mitochondrial membrane, perhaps through the opening of mito-KATP channels (Tai et al., 2003
). However, under our experimental conditions, we failed to observe any opening of either pm-KATP channels or mito-KATP channels by iptakalim. The specific subunits expressed in SNc DA neurons may contribute to the observed KATP channel insensitivity to iptakalim. It has been reported that in the SNc, DA neurons express functional KATP channels consisting of Kir6.2 and SUR1 or SUR2B subunits (Liss et al., 1999a
; Avshalumov et al., 2005
). Recently, Liss et al. (2005
) reported that the majority of KATP channels expressed in SNc DA neurons of mice (30-day-old) were mainly composed of Kir6.2 and SUR1 subunits. Pharmacologically, SUR1-containing KATP channels exhibit high sensitivity to rotenone (Liss et al., 1999a
), whereas SUR2-containing KATP channels (probably SUR2B) expressed in DA neurons are sensitive to cromakalim (Avshalumov et al., 2005
) and exhibit low sensitivity to rotenone (Liss et al., 1999a
,b
). In the present study, all DA neurons represented herein were sensitive to rotenone but insensitive to the SUR2B-selective KCO cromakalim, suggesting that the KATP channel subunits Kir6.2 and SUR1 may be predominantly expressed in rat SNc DA neurons. This conclusion is further supported by immunostaining experiments, in which dissociated rat SNc DA neurons mainly exhibited a SUR1-rather than a SUR2B-positive reaction. It is well known that the subunit combination of Kir6.2/SUR1, which forms functional KATP channels, is mainly expressed in pancreatic
-cells (Ashcroft and Gribble, 2000
; Mannhold, 2004
), whereas cardiovascular smooth muscle cells mainly express functional KATP channels composed of Kir6.2/6.1 and SUR2A/B (Ashcroft and Gribble, 2000
; Mannhold, 2004
). This difference in expression of SUR subunits determines both the affinity and efficacy of pinacidil-like (e.g., pinacidil and P1075) KCOs (Ashcroft and Gribble, 1998
, 2000
; Mannhold, 2004
). Based on previous studies, iptakalim seems to open KATP channels by binding to the SUR2A and/or SUR2B subunit because iptakalim competed against [3H]P1075 in binding to isolated smooth cells (Wang, 2003
), and [3H]iptakalim binding in the central nervous system was displaced by pinacidil or P1075 (Wang et al., 2004
). Recently, Wang's laboratory found that in heterologously expressed KATP channels in cultured HEK-293 cells, iptakalim opened SUR2A- and SUR2B-, but not SUR1-containing KATP channels (Y. P. Chen and H. Wang, unpublished data; Fig. 6B). This implies that iptakalim is incapable of opening SUR1-containing KATP channels. Therefore, it is possible that rat SNc DA neurons mainly express Kir6.2 and SUR1 subunits, which may explain why iptakalim was not able to open these KATP channels. This interpretation is consistent with previous reports that pinacidil failed to open KATP channels composed of Kir6.2 and SUR1 subunits in Xenopus oocytes (Ashfield et al., 1999
) and that A10 DA neurons were sensitive to diazoxide but not to pinacidil or lemakalim (Scuvee-Moreau et al., 1997
). Moreover, we recently found that iptakalim also failed to open KATP channels in rat pancreatic
-cells (N. Misaki, S. Suga, X. Mao, Y. F. Lin, M. Wakul, and J. Wu, unpublished data), signifying that iptakalim is incapable of opening SUR1-containing KATP channels. Therefore, it is likely that iptakalim opens SUR2A- and/or SUR2B- but not SUR1-containing KATP channels.
Instead of opening neuronal KATP channels, we surprisingly found that iptakalim closed pm-KATP channels expressed in rat SNc DA neurons. The evidence of similar inhibitory effects of iptakalim on transfected Kir6.2/SUR1 KATP channels further supports our conclusions. The mechanisms responsible for the iptakalim-induced block of pm-KATP channels are unclear, although several explanations are possible. Iptakalim may bind to glibenclamide sites of the SUR1 subunit, thereby altering SUR subunit conformation, which in turn would diminish KATP channel opening. Emerging evidence has demonstrated that iptakalim-induced pharmacological effects in the cardiovascular and central nervous systems can be prevented by pretreatment using glibenclamide (Wang et al., 2004
, 2005a
,b
,c
; Yang et al., 2005a
). Iptakalim and glibenclamide may compete for similar ligand binding sites on the SUR1 subunit. In addition, iptakalim may increase KATP channel sensitivity to ATP. It has been reported that some KATP channel modulators regulate KATP channel activity by altering KATP channel sensitivity to ATP (Suga et al., 2001
). Finally, iptakalim may directly block KATP channels by acting on the Kir6.2 subunit. It is known that some KATP channel modulators, such as nicorandil, pinacidil, or glibenclamide, regulate KATP channel activity by targeting the regulating subunit SUR (Gribble and Ashcroft, 2000a
,b
), whereas others (e.g., phentolamine and cibenzoline) directly inhibit the pore-forming subunit Kir6.2 (Proks and Ashcroft, 1997
; Mukai et al., 1998
). Ultimately, although the underlying mechanisms are unknown, the new discovery that iptakalim blocks pm-KATP channels will promote further pharmacological investigation.
The pharmacological significance of iptakalim's block of pm-KATP channels is unclear; it seems contradictory to the expectation that iptakalim should open pm-KATP channels and, in turn, protect DA neurons against chemical stress-induced neurodegeneration. However, new experimental evidence and concepts have recently emerged that KATP channels promote DA neuronal degeneration. For example, in Kir6.2 knockout mice, rotenone-induced DA neuronal death was significantly prevented, suggesting that inhibition of KATP channels may play an important role in neuroprotection (Liss et al., 2005
). From this point of view, the discovery of the blocking effects on Kir6.2/SUR1 KATP channels by iptakalim has led to a new direction in the study of the pharmacological mechanisms of its neuroprotective effects in various PD animal models using in vivo and in vitro preparations.
The present results do not support the hypothesis that iptakalim protects SNc DA neurons against chemical stress-induced neurotoxicity by directly opening pm-KATP channels and/or mito-KATP channels in the somatodendrite of DA neurons, which raises caution against the simple interpretation that effective neuroprotection induced by iptakalim against metabolic stress using in vivo animal models is via the opening of pm-KATP channels and/or mito-KATP channels in SNc DA neurons. However, our data cannot exclude other possible protective effects of iptakalim associated with the opening of KATP channels expressed in elements other than DA neurons themselves.
| Acknowledgements |
|---|
| Footnotes |
|---|
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
ABBREVIATIONS: PD, Parkinson's disease; pm, plasma membrane; mito, mitochondrial; DA, dopaminergic; SNc, substantia nigra pars compacta; SUR, sulfonylurea; HEK, human embryonic kidney; TH, tyrosine hydroxylase; PBS, phosphate-buffered saline; Rh-123, rhodamine-123; P1075, N-cyano-N''-(1,1,-dimethylpropyl)-N''-3-pyridylguanidine; DZX, diazoxide; ACSF, artificial cerebrospinal fluid.
Address correspondence to: Dr. Jie Wu, Neurophysiology Laboratory, Neurology Research, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013-4496. E-mail: Jie.Wu{at}chw.edu
| References |
|---|
|
|
|---|
Ashcroft FM and Gribble FM (1998) Correlating structure and function in ATP-sensitive K+ channels. Trends Neurosci 21: 288-294.[CrossRef][Medline]
Ashcroft FM and Gribble FM (2000) New windows on the mechanism of action of KATP channel openers. Trends Pharmacol Sci 21: 439-445.[CrossRef][Medline]
Ashfield R, Gribble FM, Ashcroft SJ, and Ashcroft FM (1999) Identification of the high-affinity tolbutamide site on the SUR1 subunit of the KATP channel. Diabetes 48: 1341-1347.[Abstract]
Avshalumov MV, Chen BT, Koos T, Tepper JM, and Rice ME (2005) Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels. J Neurosci 25: 4222-4231.
Busija DW, Lacza Z, Rajapakse N, Shimizu K, Kis B, Bari F, Domoki F, and Horiguchi T (2004) Targeting mitochondrial ATP-sensitive potassium channels: a novel approach to neuroprotection. Brain Res Brain Res Rev 46: 282-294.[CrossRef][Medline]
Chen LD (1988) Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 4: 155-181.[CrossRef][Medline]
Gribble FM and Ashcroft FM (2000a) Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues. Metabolism 49: 3-6.[Medline]
Gribble FM and Ashcroft FM (2000b) Tissue-specific effects of sulfonylureas: lessons from studies of cloned KATP channels. J Diabetes Complications 14: 192-196.[CrossRef][Medline]
Horn R and Marty A (1988) Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol 92: 145-159.
Liss B, Bruns R, and Roeper J (1999a) Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO (Eur Mol Biol Organ) J 18: 833-846.[CrossRef][Medline]
Liss B, Haeckel O, Wildmann J, Miki T, Seino S, and Roeper J (2005) K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 8: 1742-1751.[CrossRef][Medline]
Liss B, Neu A, and Roeper J (1999b) The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wvGirk2 and K-ATP channels. J Neurosci 19: 8839-8848.
Liss B and Roeper J (2001) ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction. News Physiol Sci 16: 214-217.
Mannhold R (2004) KATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev 24: 213-266.[CrossRef][Medline]
Mukai E, Ishida H, Horie M, Noma A, Seino Y, and Takano M (1998) The antiarrhythmic agent cibenzoline inhibits KATP channels by binding to Kir6.2. Biochem Biophys Res Commun 20: 477-481.
Proks P and Ashcroft FM (1997) Phentolamine block of KATP channels is mediated by Kir6.2. Proc Natl Acad Sci USA 94: 11716-11720.
Scuvee-Moreau J, Seutin V, Vrijens B, Pirotte B, De Tullio P, Massotte L, Albert A, Delarge J, and Dresse A (1997) Effect of potassium channel openers on the firing rate of hippocampal pyramidal cells and A10 dopaminergic neurons in vitro. Arch Physiol Biochem 105: 421-428.[CrossRef][Medline]
Suga S, Wu J, Ogawa Y, Takeo T, Kanno T, and Wakui M (2001) Phorbol ester impairs electrical excitation of rat pancreatic beta-cells through PKC-independent activation of KATP channels. BMC Pharmacol 1: 3-15.[CrossRef][Medline]
Tai KK, McCrossan ZA, and Abbott GW (2003) Activation of mitochondrial ATP-sensitive potassium channels increases cell viability against rotenone-induced cell death. J Neurochem 84: 1193-1200.[CrossRef][Medline]
Tai KK and Truong DD (2002) Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease. J Neurosci Res 69: 559-566.[CrossRef][Medline]
Treherne JM and Ashford ML (1991) The regional distribution of sulphonylurea binding sites in rat brain. Neuroscience 40: 523-531.[CrossRef][Medline]
Wang H (1998) ATP-sensitive potassium channel as a new target for development of antihypertensive drugs. Acta Pharmacol Sin 19: 257-267.
Wang H (2003) Pharmacological characteristics of the novel antihypertensive drug, Iptakalim hydrochloride, and its molecular mechanisms. Drug Dev Res 58: 65-68.[CrossRef]
Wang S, Hu LF, Yang Y, Ding JH, and Hu G (2005a) Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease? Neuropharmacology 48: 984-992.[CrossRef][Medline]
Wang H, Long CL, and Zhang YL (2005b) A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension. J Pharmacol Exp Ther 312: 1326-1333.
Wang H, Zhang YL, and Chen YP (2005c) Targeting small arteries of hypertensive status with novel ATP-sensitive potassium channel openers. Curr Vasc Pharmacol 3: 119-124.[CrossRef][Medline]
Wang H, Zhang YL, Tang XC, Feng HS, and Hu G (2004) Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain. Mol Pharmacol 66: 1160-1168.
Wu J, Chan P, Schroeder KM, Ellsworth K, and Partridge LD (2002) 1-Methyl-4.-phenylpridinium (MPP+)-induced functional run-down of GABAA receptor-mediated currents in acutely dissociated dopaminergic neurons. J Neurochem 83: 87-99.[CrossRef][Medline]
Wu J, George AA, Schroeder KM, Xu L, Marxer-Miller S, Lucero L, and Lukas RJ (2004) Electrophysiological, pharmacological, and molecular evidence for
7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. J Pharmacol Exp Ther 311: 80-91.
Wu J and Partridge LD (1998) Dissociated dopaminergic neurons from substantia nigra zona compacta in young rats lack functional NMDA receptors. Pfluegers Arch Eur J Physiol 435: 699-704.[CrossRef][Medline]
Yamada K and Inagaki N (2005) Neuroprotection by KATP channels. J Mol Cell Cardiol 38: 945-949.[CrossRef][Medline]
Yang Y, Liu X, Long Y, Wang F, Ding JH, Liu SY, Sun YH, Yao HH, Wang H, Wu J, et al. (2005a) Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. Int J Neuropsychopharmacol 1: 1-11.[Medline]
Yang Y, Liu X, Long Y, Wang F, Ding JH, Liu SY, Sun YH, Yao HH, Wang H, Wu J, et al. (2005b) Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats. J Neurosci Res 80: 442-449.[CrossRef][Medline]
Yang YL, Meng CH, Ding JH, He HR, Ellsworth K, Wu J, and Hu G (2005c) Iptakalim hydrochloride protects cells against neurotoxin-induced glutamate transporter dysfunction in in vitro and in vivo models. Brain Res 1049: 80-88.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
N. Misaki, X. Mao, Y.-F. Lin, S. Suga, G.-H. Li, Q. Liu, Y. Chang, H. Wang, M. Wakui, and J. Wu Iptakalim, a Vascular ATP-Sensitive Potassium (KATP) Channel Opener, Closes Rat Pancreatic beta-Cell KATP Channels and Increases Insulin Release J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 871 - 878. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||